Download data is not yet available.


Tumor-infiltrating lymphocytes (TIL) are associated with survival in virtually every human cancer studied, but the mechanisms by which they confer protective immunity remain incompletely understood. Focusing on ovarian cancer, our group applies genomic and molecular pathology approaches to define the mechanisms by which the immune system responds to the evolving tumor genome over space and time. We have shown that optimal anti-tumor immunity involves interactions between T cells and antibody-producing B cells and plasma cells in the tumor microenvironment. Moreover, we have identified three patterns of TIL response in ovarian cancer, each carrying distinct implications for immunotherapy. We are translating these insights into clinical trials involving adoptive transfer of tumor-reactive T cells.

Author's Affiliation

 Copyright Info

Creative Commons License

Copyright: The Authors. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 How to Cite
Nelson, B. (2017). ID:4002 Customizing cancer immunotherapies to match the intrinsic tumor microenvironment. Biomedical Research and Therapy, 4(S), S4.

 Cited by

Article level Metrics by Paperbuzz/Impactstory
Article level Metrics by Altmetrics

 Article Statistics
HTML = 144 times
Download PDF   = 43 times
Total   = 43 times